Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention | Zendy

Morten Lamberts | Zendy; Jonas Bjerring Olesen | Zendy; Martin H. Ruwald | Zendy; Carolina Malta Hansen | Zendy; Deniz Karasoy | Zendy; Søren Lund Kristensen | Zendy; Lars Køber | Zendy; Christian TorpPedersen | Zendy; Gunnar Gislason | Zendy; Morten Lock Hansen | Zendy

Open Access

Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention

Author(s) -

Morten Lamberts,

Jonas Bjerring Olesen,

Martin H. Ruwald,

Carolina Malta Hansen,

Deniz Karasoy,

Søren Lund Kristensen,

Lars Køber,

Christian TorpPedersen,

Gunnar Gislason,

Morten Lock Hansen

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.112.114967

Subject(s) - medicine , antithrombotic , atrial fibrillation , cardiology , myocardial infarction , percutaneous coronary intervention , intervention (counseling) , fibrinolytic agent , psychiatry

Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or undergoing percutaneous coronary intervention. We investigated the risk and time frame for bleeding following myocardial infarction/percutaneous coronary intervention in patients with atrial fibrillation according to antithrombotic treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research